Business Context and Reporting Period
Company: PACS Group, Inc. (PACS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: PACS is a leading post-acute healthcare company operating 321 skilled nursing facilities (SNFs) across 17 states. The company utilizes a "locally led, centrally supported" model to acquire underperforming custodial care facilities and transform them into higher-acuity, short-term transitional care facilities. As of December 31, 2025, the portfolio included 150 Mature, 102 Ramping, and 69 New facilities.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenue | $5.29 billion | $4.09 billion | +29.3% |
| Net Income | $191.5 million | $55.3 million | +245.9% |
| Adjusted EBITDA | $505.0 million | $279.5 million | +80.7% |
| Operating Income | $309.6 million | $123.1 million | +151.6% |
| Operating Margin | 5.9% | 3.0% | +2.9 pts |
| Cash from Operations | $404.2 million | $367.3 million | +10.0% |
| Long-Term Liabilities | $3.6 billion | $3.6 billion | ~0% |
| Cash & Equivalents | $197.0 million | $157.7 million | +24.9% |
Key Operational Metrics (2025):
- Occupancy Rate: 89.1% (Total); 94.9% (Mature Facilities)
- Skilled Mix (Revenue): 48.8% (Total); 56.0% (Mature Facilities)
- Payor Mix: Medicare (33.7%), Medicaid (40.5%), Managed Care (18.7%)
Material Changes vs. Prior Period
- Revenue Growth: Driven primarily by a 22.8% increase in patient days due to significant acquisitions in late 2024 (notably the Prestige acquisition) and continued organic growth in Mature facilities.
- Profitability Surge: Net income increased 246% year-over-year, fueled by a 152% jump in operating income. This was supported by improved operational performance and a decrease in stock-based compensation expense ($61.5 million reduction) compared to the IPO year.
- Expense Increases: Cost of services rose 25.3% ($832.6 million), primarily due to a $536 million increase in salaries and wages driven by new facility integration and market wage pressures. General and administrative expenses increased 20.7%, largely due to $87.3 million in legal and professional fees related to ongoing investigations.
- Facility Portfolio: The company added 8 facilities in 2025 and divested 1. The number of Mature facilities increased to 150, which continue to outperform industry averages in quality ratings (4.4 Stars) and occupancy (95%).
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management expects to continue executing its acquisition strategy, targeting underperforming facilities to convert into high-acuity transitional care centers. The company anticipates retaining future earnings for growth and does not plan to pay dividends in the foreseeable future. Growth levers include expanding in existing/new markets, leveraging operational upside in the "Ramping" and "New" facility cohorts, and extracting value from real estate ownership.
Material Risks and Contingencies
- Internal Control Weaknesses: The company identified material weaknesses in internal controls over financial reporting for 2024 and 2025, specifically regarding revenue recognition processes and risk communication. These weaknesses led to a restatement of prior interim financial statements and an adverse opinion from auditors on internal controls.
- Regulatory Investigations: PACS is subject to multiple ongoing investigations by the U.S. Department of Justice (DOJ) and the SEC. These include Civil Investigative Demands (CIDs) regarding potential False Claims Act violations (patient referrals, billing practices) and a criminal subpoena under HIPAA. The company cannot predict the outcome or potential financial impact.
- Legal Proceedings: The company is a defendant in a securities class action lawsuit and derivative litigation following a short-seller report in November 2024 alleging revenue inflation and billing fraud.
- Reimbursement Risk: Revenue is heavily dependent on Medicare (33.7%) and Medicaid (40.5%). Changes in reimbursement rates, the "One Big Beautiful Bill Act" (OBBBA) reducing Medicaid funding, and increased regulatory scrutiny pose significant risks to margins.
- Debt Covenants: The company has a $600 million credit facility. It recently entered into multiple forbearance agreements and amendments to waive technical events of default related to financial statement delivery and representation inaccuracies. A liquidity requirement of $100 million in unrestricted cash remains in place until June 30, 2026.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation plans for the identified material weaknesses in revenue recognition and compliance reporting.
- Investigation Outcomes: Monitor developments in the DOJ and SEC investigations regarding False Claims Act and HIPAA violations to assess potential fines, penalties, or restatements.
- Debt Covenant Compliance: Confirm continued compliance with the credit facility's financial covenants (Total Leverage Ratio ≤ 3.00:1.00; Fixed Charge Coverage Ratio ≥ 1.10:1.00) and the $100 million liquidity requirement.
- Self-Insurance Reserves: Review the adequacy of the $296 million professional liability and general liability self-insurance reserves, which are a critical audit matter.
- Acquisition Integration: Assess the performance trajectory of the 69 "New" and 102 "Ramping" facilities to ensure they meet the projected improvement in skilled mix and occupancy rates.